A Phase 1 Study Of FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia

NCT07428486 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped PI requested

Conditions

Phase I
FLAG Chemotherapy
Lisaftoclax
Pelcitoclax
Relapsed/Refractory
Lymphoblastic Leukemia Acute

Interventions

DRUG: Fludarabine
DRUG: Cytarabine
DRUG: G-CSF
DRUG: Lisaftoclax
DRUG: Pelcitoclax

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]